FHS
0.002
100%
LIB
0.002
-33.3%
AHNDA
0.09
76.5%
PER
0.003
-25%
AMD
0.005
66.7%
MHM
0.12
-17.2%
BLU
0.004
33.3%
SHO
0.039
-17%
JCS
0.04
33.3%
CCX
0.054
-16.9%
TAT
0.026
30%
BTN
0.015
-16.7%
PET
0.006
20%
GNM
0.035
-16.7%
AHF
0.019
18.8%
IPD
0.005
-16.7%
CYG
0.395
17.9%
XRA
0.18
-16.3%
BSR
0.34
17.2%
EM3
0.12
-15.5%
RFT
0.007
16.7%
CPO
0.011
-15.4%
CHL
0.19
15.2%
REE
0.011
-15.4%
EMC
0.115
15%
AXQ
4.61
-15.1%
BUX
0.047
14.6%
AON
0.047
-14.5%
LCL
0.008
14.3%
4DX
3.245
-14.4%
ALB
0.051
13.3%
BNL
0.006
-14.3%
CDE
0.009
12.5%
EXT
0.006
-14.3%
D3E
0.345
11.3%
FEL
0.006
-14.3%
88E
0.02
11.1%
PL9
0.006
-14.3%
SER
0.15
11.1%
PNT
0.006
-14.3%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Imricor Medical Systems (ASX: IMR): Awarded CE mark approval

Developer of MRI-compatible devices, Imricor Medical Systems (ASX: IMR) has been awarded CE mark certification from the EU for its Vision-MR Diagnostic Catheter, allowing for manufacturing and release into the clinical market | ASX announcement: https://announcements.asx.com.au/asxpdf/20240306/pdf/0616gfxf12g8pc.pdf